{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:46:43Z","timestamp":1783979203013,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10515-0","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:09:51Z","timestamp":1745903391000},"page":"883-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A spotlight on congestion in acute heart failure: a joint session with the Romanian Society of Cardiology (part I)"],"prefix":"10.1007","volume":"30","author":[{"given":"Linda","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena-Laura","family":"Antohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliviana","family":"Geavlete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishay","family":"Grupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Palazzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"11","key":"10515_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","volume":"34","author":"AP Ambrosy","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S et al (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34(11):835\u2013843. https:\/\/doi.org\/10.1093\/eurheartj\/ehs444","journal-title":"Eur Heart J"},{"issue":"1","key":"10515_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee J, Mann DL (2017) Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol 14(1):30\u201338. https:\/\/doi.org\/10.1038\/nrcardio.2016.163","journal-title":"Nat Rev Cardiol"},{"issue":"13","key":"10515_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2024.01.029","volume":"83","author":"G Cotter","year":"2024","unstructured":"Cotter G, Davison B, Chioncel O (2024) Enhanced decongestive therapy in patients with acute heart failure. J Am Coll Cardiol 83(13):1243\u20131252. https:\/\/doi.org\/10.1016\/j.jacc.2024.01.029","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10515_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.111.961789","volume":"4","author":"C Fallick","year":"2011","unstructured":"Fallick C, Sobotka PA, Dunlap ME (2011) Sympathetically mediated changes in capacitance. Circ Hear Fail 4(5):669\u2013675. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.111.961789","journal-title":"Circ Hear Fail"},{"issue":"8","key":"10515_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jchf.2023.05.034","volume":"11","author":"J Biegus","year":"2023","unstructured":"Biegus J, Borlaug BA, Testani JM (2023) Congestion and decongestion assessment in heart failure. JACC Hear Fail 11(8):1152\u20131156. https:\/\/doi.org\/10.1016\/j.jchf.2023.05.034","journal-title":"JACC Hear Fail"},{"issue":"14","key":"10515_CR6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.107.690768","volume":"116","author":"SI Chaudhry","year":"2007","unstructured":"Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM (2007) Patterns of weight change preceding hospitalization for heart failure. Circulation 116(14):1549\u20131554. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.690768","journal-title":"Circulation"},{"key":"10515_CR7","doi-asserted-by":"publisher","unstructured":"Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Hear Journal, Suppl. 2005;7(B). https:\/\/doi.org\/10.1093\/eurheartj\/sui008","DOI":"10.1093\/eurheartj\/sui008"},{"issue":"10","key":"10515_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Anker SD, Dahlstr\u00f6m U et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 15(10):1173\u20131184. https:\/\/doi.org\/10.1093\/eurjhf\/hft134","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10515_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jchf.2020.05.013","volume":"8","author":"SJ Greene","year":"2020","unstructured":"Greene SJ, Triana TS, Ionescu-Ittu R et al (2020) In-hospital therapy for heart failure with reduced ejection fraction in the United States. JACC Hear Fail 8(11):943\u2013953. https:\/\/doi.org\/10.1016\/j.jchf.2020.05.013","journal-title":"JACC Hear Fail"},{"issue":"8","key":"10515_CR10","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jchf.2024.04.002","volume":"12","author":"J Zheng","year":"2024","unstructured":"Zheng J, Ambrosy AP, Bhatt AS et al (2024) Contemporary decongestion strategies in patients hospitalized for heart failure: a national community-based cohort study. JACC Hear Fail 12(8):1381\u20131392. https:\/\/doi.org\/10.1016\/j.jchf.2024.04.002","journal-title":"JACC Hear Fail"},{"issue":"2","key":"10515_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams","year":"2005","unstructured":"Adams KF, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149(2):209\u2013216. https:\/\/doi.org\/10.1016\/j.ahj.2004.08.005","journal-title":"Am Heart J"},{"issue":"15","key":"10515_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jacc.2012.07.011","volume":"60","author":"C Partovian","year":"2012","unstructured":"Partovian C, Gleim SR, Mody PS et al (2012) Hospital patterns of use of positive inotropic agents in patients with heart failure. J Am Coll Cardiol 60(15):1402\u20131409. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10515_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ahj.2006.09.005","volume":"153","author":"U Elkayam","year":"2007","unstructured":"Elkayam U, Tasissa G, Binanay C et al (2007) Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153(1):98\u2013104. https:\/\/doi.org\/10.1016\/j.ahj.2006.09.005","journal-title":"Am Heart J"},{"issue":"2","key":"10515_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ejhf.3162","volume":"26","author":"M Riccardi","year":"2024","unstructured":"Riccardi M, Pagnesi M, Chioncel O et al (2024) Medical therapy of cardiogenic shock: contemporary use of inotropes and vasopressors. Eur J Heart Fail 26(2):411\u2013431. https:\/\/doi.org\/10.1002\/ejhf.3162","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10515_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejhf.1236","volume":"20","author":"MG Crespo-Leiro","year":"2018","unstructured":"Crespo-Leiro MG, Metra M, Lund LH et al (2018) Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20(11):1505\u20131535. https:\/\/doi.org\/10.1002\/ejhf.1236","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10515_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/clc.4960270107","volume":"27","author":"A L\u00f3pez-Candales","year":"2004","unstructured":"L\u00f3pez-Candales A, Carron C, Schwartz J (2004) Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. Clin Cardiol 27(1):23\u201328. https:\/\/doi.org\/10.1002\/clc.4960270107","journal-title":"Clin Cardiol"},{"issue":"4","key":"10515_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ehf2.12248","volume":"5","author":"P Martens","year":"2018","unstructured":"Martens P, Vercammen J, Ceyssens W et al (2018) Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure. ESC Hear Fail 5(4):562\u2013569. https:\/\/doi.org\/10.1002\/ehf2.12248","journal-title":"ESC Hear Fail"},{"issue":"36","key":"10515_CR18","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"12","key":"10515_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe MS (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure<subtitle>a randomized controlled trial<\/SUBTITLE>. JAMA 287(12):1541. https:\/\/doi.org\/10.1001\/jama.287.12.1541","journal-title":"JAMA"},{"issue":"11","key":"10515_CR20","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP et al (2019) Acute heart failure congestion and perfusion status \u2013 impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 21(11):1338\u20131352. https:\/\/doi.org\/10.1002\/ejhf.1492","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10515_CR21","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/eurjpc\/zwad151","volume":"30","author":"O Chioncel","year":"2023","unstructured":"Chioncel O, Benson L, Crespo-Leiro MG et al (2023) Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry. Eur J Prev Cardiol 30(13):1346\u20131358. https:\/\/doi.org\/10.1093\/eurjpc\/zwad151","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"10515_CR22","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10515_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/ejhf.344","volume":"17","author":"S Coiro","year":"2015","unstructured":"Coiro S, Rossignol P, Ambrosio G et al (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17(11):1172\u20131181. https:\/\/doi.org\/10.1002\/ejhf.344","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10515_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2016.09.012","volume":"5","author":"AP Ambrosy","year":"2017","unstructured":"Ambrosy AP, Cerbin LP, Armstrong PW et al (2017) Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes. JACC Hear Fail 5(1):1\u201313. https:\/\/doi.org\/10.1016\/j.jchf.2016.09.012","journal-title":"JACC Hear Fail"},{"issue":"4","key":"10515_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","volume":"43","author":"D Logeart","year":"2004","unstructured":"Logeart D, Thabut G, Jourdain P et al (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43(4):635\u2013641. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.044","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10515_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12265-020-09954-x","volume":"13","author":"R Masson","year":"2020","unstructured":"Masson R, Ambrosy AP, Kheder K et al (2020) A novel in-hospital congestion score to risk stratify patients admitted for worsening heart failure (from ASCEND-HF). J Cardiovasc Transl Res 13(4):540\u2013548. https:\/\/doi.org\/10.1007\/s12265-020-09954-x","journal-title":"J Cardiovasc Transl Res"},{"key":"10515_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.09.013","author":"M Pagnesi","year":"2024","unstructured":"Pagnesi M, Staal L, Ter Maaten JM et al (N 2024) Decongestion and outcomes in patients hospitalized for acute heart failure: insights from the RELAX-AHF-2 trial. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2024.09.013","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10515_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jacc.2017.05.052","volume":"70","author":"WT Abraham","year":"2017","unstructured":"Abraham WT, Perl L (2017) Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol 70(3):389\u2013398. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.052","journal-title":"J Am Coll Cardiol"},{"key":"10515_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejim.2021.11.010","volume":"97","author":"C Cogliati","year":"2022","unstructured":"Cogliati C, Ceriani E, Gambassi G et al (2022) Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: the Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study. Eur J Intern Med 97:69\u201377. https:\/\/doi.org\/10.1016\/j.ejim.2021.11.010","journal-title":"Eur J Intern Med"},{"key":"10515_CR30","doi-asserted-by":"publisher","unstructured":"Pham DD, Drazner MH, Ayers CR, et al. Identifying discordance of right- and left-ventricular filling pressures in patients with heart failure by the clinical examination. Circ Hear Fail. 2021;14(11). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008779","DOI":"10.1161\/CIRCHEARTFAILURE.121.008779"},{"issue":"4","key":"10515_CR31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ejhf.1050","volume":"20","author":"LNL Van Aelst","year":"2018","unstructured":"Van Aelst LNL, Arrigo M, Placido R et al (2018) Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion. Eur J Heart Fail 20(4):738\u2013747. https:\/\/doi.org\/10.1002\/ejhf.1050","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10515_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jacc.2024.04.055","volume":"84","author":"J Biegus","year":"2024","unstructured":"Biegus J, Mebazaa A, Davison B et al (2024) Effects of rapid uptitration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF. J Am Coll Cardiol 84(4):323\u2013336. https:\/\/doi.org\/10.1016\/j.jacc.2024.04.055","journal-title":"J Am Coll Cardiol"},{"issue":"10367","key":"10515_CR33","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O et al (2022) Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400(10367):1938\u20131952. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1","journal-title":"Lancet"},{"issue":"13","key":"10515_CR34","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P et al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387(13):1185\u20131195. https:\/\/doi.org\/10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"issue":"10017","key":"10515_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","volume":"387","author":"WT Abraham","year":"2016","unstructured":"Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB (2016) Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 387(10017):453\u2013461. https:\/\/doi.org\/10.1016\/S0140-6736(15)00723-0","journal-title":"Lancet"},{"issue":"11","key":"10515_CR36","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.cardfail.2016.09.012","volume":"22","author":"WT Abraham","year":"2016","unstructured":"Abraham WT, Adamson PB, Costanzo MR et al (2016) Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial. J Card Fail 22(11):940. https:\/\/doi.org\/10.1016\/j.cardfail.2016.09.012","journal-title":"J Card Fail"},{"issue":"10304","key":"10515_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","volume":"398","author":"J Lindenfeld","year":"2021","unstructured":"Lindenfeld J, Zile MR, Desai AS et al (2021) Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet 398(10304):991\u20131001. https:\/\/doi.org\/10.1016\/S0140-6736(21)01754-2","journal-title":"Lancet"},{"issue":"6","key":"10515_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jacc.2023.11.030","volume":"83","author":"J Lindenfeld","year":"2024","unstructured":"Lindenfeld J, Costanzo MR, Zile MR et al (2024) Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 83(6):682\u2013694. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.030","journal-title":"J Am Coll Cardiol"},{"key":"10515_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ahj.2024.07.015","volume":"277","author":"LM Burgos","year":"2024","unstructured":"Burgos LM, Baro Vila RC, Ballari FN et al (2024) Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: a randomized pilot study (CAVAL US-AHF study). Am Heart J 277:47\u201357. https:\/\/doi.org\/10.1016\/j.ahj.2024.07.015","journal-title":"Am Heart J"},{"issue":"9","key":"10515_CR40","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"issue":"24","key":"10515_CR41","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","volume":"367","author":"BA Bart","year":"2012","unstructured":"Bart BA, Goldsmith SR, Lee KL et al (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367(24):2296\u20132304. https:\/\/doi.org\/10.1056\/NEJMoa1210357","journal-title":"N Engl J Med"},{"issue":"3","key":"10515_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","volume":"8","author":"ZL Cox","year":"2020","unstructured":"Cox ZL, Hung R, Lenihan DJ, Testani JM (2020) Diuretic strategies for loop diuretic resistance in acute heart failure. JACC Hear Fail 8(3):157\u2013168. https:\/\/doi.org\/10.1016\/j.jchf.2019.09.012","journal-title":"JACC Hear Fail"},{"issue":"11","key":"10515_CR43","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.jacc.2016.12.035","volume":"69","author":"MA Konstam","year":"2017","unstructured":"Konstam MA, Kiernan M, Chandler A et al (2017) Short-term effects of tolvaptan in patients with acute heart failure and volume overload. J Am Coll Cardiol 69(11):1409\u20131419. https:\/\/doi.org\/10.1016\/j.jacc.2016.12.035","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10515_CR44","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","volume":"69","author":"GM Felker","year":"2017","unstructured":"Felker GM, Mentz RJ, Cole RT et al (2017) Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure. J Am Coll Cardiol 69(11):1399\u20131406. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.004","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10515_CR45","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure<subtitle>the EVEREST outcome trial<\/subtitle>. JAMA 297(12):1319. https:\/\/doi.org\/10.1001\/jama.297.12.1319","journal-title":"JAMA"},{"issue":"5","key":"10515_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","volume":"44","author":"JC Trull\u00e0s","year":"2023","unstructured":"Trull\u00e0s JC, Morales-Rull JL, Casado J et al (2023) Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J 44(5):411\u2013421. https:\/\/doi.org\/10.1093\/eurheartj\/ehac689","journal-title":"Eur Heart J"},{"key":"10515_CR47","doi-asserted-by":"publisher","unstructured":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. JAMA. 2002;287(12). https:\/\/doi.org\/10.1001\/jama.287.12.1531","DOI":"10.1001\/jama.287.12.1531"},{"issue":"4","key":"10515_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ahj.2013.12.023","volume":"167","author":"WF Peacock","year":"2014","unstructured":"Peacock WF, Chandra A, Char D et al (2014) Clevidipine in acute heart failure: results of the A Study of Blood Pressure Control in Acute Heart Failure\u2014a pilot study (PRONTO). Am Heart J 167(4):529\u2013536. https:\/\/doi.org\/10.1016\/j.ahj.2013.12.023","journal-title":"Am Heart J"},{"issue":"9860","key":"10515_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink JR, Cotter G, Davison BA et al (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381(9860):29\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(12)61855-8","journal-title":"Lancet"},{"issue":"8","key":"10515_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1801291","volume":"381","author":"M Metra","year":"2019","unstructured":"Metra M, Teerlink JR, Cotter G et al (2019) Effects of serelaxin in patients with acute heart failure. N Engl J Med 381(8):716\u2013726. https:\/\/doi.org\/10.1056\/NEJMoa1801291","journal-title":"N Engl J Med"},{"issue":"23","key":"10515_CR51","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1001\/jama.2013.282190","volume":"310","author":"HH Chen","year":"2013","unstructured":"Chen HH, Anstrom KJ, Givertz MM et al (2013) Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction. JAMA 310(23):2533. https:\/\/doi.org\/10.1001\/jama.2013.282190","journal-title":"JAMA"},{"issue":"23","key":"10515_CR52","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2019.18598","volume":"322","author":"N Kozhuharov","year":"2019","unstructured":"Kozhuharov N, Goudev A, Flores D et al (2019) Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure. JAMA 322(23):2292. https:\/\/doi.org\/10.1001\/jama.2019.18598","journal-title":"JAMA"},{"issue":"19","key":"10515_CR53","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1001\/jama.2020.19378","volume":"324","author":"Y Freund","year":"2020","unstructured":"Freund Y, Cachanado M, Delannoy Q et al (2020) Effect of an emergency department care bundle on 30-day hospital discharge and survival among elderly patients with acute heart failure. JAMA 324(19):1948. https:\/\/doi.org\/10.1001\/jama.2020.19378","journal-title":"JAMA"},{"issue":"1","key":"10515_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","volume":"20","author":"M Packer","year":"1992","unstructured":"Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20(1):248\u2013254. https:\/\/doi.org\/10.1016\/0735-1097(92)90167-L","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10515_CR55","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/nejmoa1812851","volume":"380","author":"EJ Velazquez","year":"2019","unstructured":"Velazquez EJ, Morrow DA, DeVore AD et al (2019) Angiotensin\u2013neprilysin inhibition in acute decompensated heart failure. N Engl J Med 380(6):539\u2013548. https:\/\/doi.org\/10.1056\/nejmoa1812851","journal-title":"N Engl J Med"},{"issue":"19","key":"10515_CR56","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","volume":"139","author":"DA Morrow","year":"2019","unstructured":"Morrow DA, Velazquez EJ, Devore AD et al (2019) Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril\/valsartan or enalapril in the PIONEER-HF trial. Circulation 139(19):2285\u20132288. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039331","journal-title":"Circulation"},{"issue":"2","key":"10515_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamacardio.2019.4665","volume":"5","author":"AD DeVore","year":"2020","unstructured":"DeVore AD, Braunwald E, Morrow DA et al (2020) Initiation of angiotensin-neprilysin inhibition after acute decompensated heart failure: secondary analysis of the open-label extension of the PIONEER-HF trial. JAMA Cardiol 5(2):202\u2013207. https:\/\/doi.org\/10.1001\/jamacardio.2019.4665","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10515_CR58","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","volume":"133","author":"SA Hubers","year":"2016","unstructured":"Hubers SA, Brown NJ (2016) Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation 133(11):1115\u20131124. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018622","journal-title":"Circulation"},{"issue":"8","key":"10515_CR59","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ejhf.1498","volume":"21","author":"R Wachter","year":"2019","unstructured":"Wachter R, Senni M, Belohlavek J et al (2019) Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail 21(8):998\u20131007. https:\/\/doi.org\/10.1002\/ejhf.1498","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10515_CR60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","volume":"146","author":"PC Schulze","year":"2022","unstructured":"Schulze PC, Bogoviku J, Westphal J et al (2022) Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF). Circulation 146(4):289\u2013298. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059038","journal-title":"Circulation"},{"issue":"11","key":"10515_CR61","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","volume":"142","author":"M Griffin","year":"2020","unstructured":"Griffin M, Rao VS, Ivey-Miranda J et al (2020) Empagliflozin in heart failure. Circulation 142(11):1028\u20131039. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045691","journal-title":"Circulation"},{"issue":"1","key":"10515_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","volume":"44","author":"J Biegus","year":"2023","unstructured":"Biegus J, Voors AA, Collins SP et al (2023) Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J 44(1):41\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehac530","journal-title":"Eur Heart J"},{"issue":"14","key":"10515_CR63","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","volume":"83","author":"ZL Cox","year":"2024","unstructured":"Cox ZL, Collins SP, Hernandez GA et al (2024) Efficacy and safety of dapagliflozin in patients with acute heart failure. J Am Coll Cardiol 83(14):1295\u20131306. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.009","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10515_CR64","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/ejhf.1575","volume":"21","author":"A Kimmoun","year":"2019","unstructured":"Kimmoun A, Cotter G, Davison B et al (2019) Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study. Eur J Heart Fail 21(11):1459\u20131467. https:\/\/doi.org\/10.1002\/ejhf.1575","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10515_CR65","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/ejhf.2348","volume":"23","author":"G Cotter","year":"2021","unstructured":"Cotter G, Davison B, Metra M et al (2021) Amended STRONG-HF study design. Eur J Heart Fail 23(11):1981\u20131982. https:\/\/doi.org\/10.1002\/ejhf.2348","journal-title":"Eur J Heart Fail"},{"issue":"31","key":"10515_CR66","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/eurheartj\/ehad335","volume":"44","author":"M Adamo","year":"2023","unstructured":"Adamo M, Pagnesi M, Mebazaa A et al (2023) NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial. Eur Heart J 44(31):2947\u20132962. https:\/\/doi.org\/10.1093\/eurheartj\/ehad335","journal-title":"Eur Heart J"},{"issue":"7","key":"10515_CR67","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/ejhf.3336","volume":"26","author":"G Voordes","year":"2024","unstructured":"Voordes G, Davison B, Biegus J et al (2024) Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF. Eur J Heart Fail 26(7):1480\u20131492. https:\/\/doi.org\/10.1002\/ejhf.3336","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10515_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ejhf.1678","volume":"22","author":"J \u010celutkien\u0117","year":"2020","unstructured":"\u010celutkien\u0117 J, Lainscak M, Anderson L et al (2020) Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 22(2):181\u2013195. https:\/\/doi.org\/10.1002\/ejhf.1678","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10515_CR69","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ejhf.1697","volume":"22","author":"W Mullens","year":"2020","unstructured":"Mullens W, Damman K, Testani JM et al (2020) Evaluation of kidney function throughout the heart failure trajectory \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 22(4):584\u2013603. https:\/\/doi.org\/10.1002\/ejhf.1697","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10515-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10515-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10515-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:02:49Z","timestamp":1753905769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10515-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["10515"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10515-0","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"17 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Lainscak receives support from Slovenian Research and Innovation Agency (Grant no. P3-0456). Dr. Collins receives research support from NIH, PCORI, and DOD and is a consultant for Abbott, Boehringer Ingelheim, Corteria, Prenosis, Reprieve Cardiovascular, and Tosoh. Dr. Ambrosy has received relevant research support through grants to his institution from the National Heart, Lung, and Blood Institute (K23HL150159 and R01 AG091005), the American Heart Association (2nd Century Early Faculty Independence Award), The Permanente Medical Group, Northern California Community Benefits Programs, Garfield Memorial Fund, Abbott Laboratories, Amarin Pharma, Inc., Bayer, Cordio Medical, Edwards Lifesciences LLC, Esperion Therapeutics, Inc., Merck, and Novartis. Dr. Ambrosy is an Editorial Board Member of the Heart Failure Reviews journal. All other authors report no relevant disclosures. All other authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Lainscak receives support from Slovenian Research and Innovation Agency (Grant nr. P3-0456). Dr. Collins receives research support from NIH, PCORI and DOD and is a consultant for Abbott, Boehringer Ingelheim, Corteria, Prenosis, Reprieve Cardiovascular and Tosoh. Dr. Ambrosy has received relevant research support through grants to his institution from the National Heart, Lung, and Blood Institute (K23HL150159 and R01 AG091005), the American Heart Association (2nd Century Early Faculty Independence Award), The Permanente Medical Group, Northern California Community Benefits Programs, Garfield Memorial Fund, Abbott Laboratories, Amarin Pharma, Inc., Bayer, Cordio Medical, Edwards Lifesciences LLC, Esperion Therapeutics, Inc., Merck, and Novartis. All other authors report no relevant disclosures. Dr. Ambrosy is an Editorial Board Member of the Heart Failure Reviews journal. All other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}